Research article · 27 Jul 2026
EditorialPublished 7 Jan 2026
Advancing Drug Development With Pharmacokinetic Modeling
Department of Clinical Pharmacology, Horizon College of Health Sciences, Nova Valley University, Orion City, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmacokinetic modeling is fundamental to drug development, guiding dose optimization and predicting interactions. Modern approaches integrate mechanistic insights with population data, utilize PBPK for ADME simulation, and leverage AI/ML for enhanced prediction. PK/PD modeling connects drug exposure to effects, while QSP offers system-level mechanistic understanding. Challenges with sparse data are being addressed, and Bayesian modeling enables adaptive dosing for improved safety and efficacy. These techniques collectively advance drug discovery and clinical application
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Dr. Aarav Mehta”
